Information Provided By: 
Fly News Breaks for August 12, 2019
VMD
Aug 12, 2019 | 09:01 EDT
Lake Street analyst Brooks O'Neil raised his price target for Viemed Healthcare to $12 from $10 after the company announced that its common shares were approved for listing on the Nasdaq Capital Market. Viemed is a self-funding 45% organic grower with an entrepreneurial management team and large total addressable market, O'Neil tells investors in a research note. He also views last week's Q2 results as "solid."
News For VMD From the Last 2 Days
There are no results for your query VMD
